Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab

Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab

Introduction: Lymphoproliferative disorders, particularly non-Hodgkin's and Hodgkin's lymphomas, are rare in patients with inflammatory bowel diseases. The use of thiopurines and infection by Epstein-Barr virus are well-known cofactors that can raise its prevalence. Other risk factors such...

Full description

Bibliographic Details
Main Authors: Diana Carvalho, Pedro Russo, Carlos Bernardes, Joana Saiote, Gonçalo Ramos, Luís Mascarenhas, Nuno Borges, Jaime Ramos
Format: Article
Language:English
Published: Karger Publishers 2017-09-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
Crohn’s disease
Hodgkin’s disease, chemically induced
Infliximab
Lymphoproliferative disorders
Tumor necrosis factor-α
Online Access:http://www.karger.com/Article/FullText/455180

Internet

http://www.karger.com/Article/FullText/455180

Similar Items